Lead programme based on a first--in--class small--molecule E6AP ubiquitin ligase inhibition strategy for the treatment of HPV--positive head and neck cancer -- Programme has demonstrated strong in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results